MariMed Inc (MRMD)
0.1641
0.00 (0.00%)
USD |
OTCM |
Nov 05, 15:56
MariMed Enterprise Value: 123.47M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 123.47M |
| November 01, 2024 | 122.86M |
| October 31, 2024 | 122.37M |
| October 30, 2024 | 123.13M |
| October 29, 2024 | 123.32M |
| October 28, 2024 | 124.27M |
| October 25, 2024 | 124.27M |
| October 24, 2024 | 123.32M |
| October 23, 2024 | 125.79M |
| October 22, 2024 | 126.17M |
| October 21, 2024 | 124.03M |
| October 18, 2024 | 122.75M |
| October 17, 2024 | 126.17M |
| October 16, 2024 | 126.17M |
| October 15, 2024 | 123.32M |
| October 14, 2024 | 125.03M |
| October 11, 2024 | 120.46M |
| October 10, 2024 | 118.18M |
| October 09, 2024 | 118.56M |
| October 08, 2024 | 118.75M |
| October 07, 2024 | 118.56M |
| October 04, 2024 | 121.22M |
| October 03, 2024 | 120.84M |
| October 02, 2024 | 120.46M |
| October 01, 2024 | 125.41M |
| Date | Value |
|---|---|
| September 30, 2024 | 126.93M |
| September 27, 2024 | 126.17M |
| September 26, 2024 | 126.44M |
| September 25, 2024 | 126.88M |
| September 24, 2024 | 127.12M |
| September 23, 2024 | 126.10M |
| September 20, 2024 | 123.20M |
| September 19, 2024 | 126.17M |
| September 18, 2024 | 126.17M |
| September 17, 2024 | 124.27M |
| September 16, 2024 | 125.03M |
| September 13, 2024 | 125.03M |
| September 12, 2024 | 126.17M |
| September 11, 2024 | 127.69M |
| September 10, 2024 | 128.38M |
| September 09, 2024 | 130.36M |
| September 06, 2024 | 123.47M |
| September 05, 2024 | 123.13M |
| September 04, 2024 | 122.75M |
| September 03, 2024 | 124.46M |
| August 30, 2024 | 132.07M |
| August 29, 2024 | 129.60M |
| August 28, 2024 | 128.46M |
| August 27, 2024 | 136.83M |
| August 26, 2024 | 144.44M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
67.23M
Minimum
Mar 12 2020
372.95M
Maximum
Jun 03 2021
180.45M
Average
171.48M
Median
Jun 16 2023
Enterprise Value Benchmarks
| cbdMD Inc | 0.719M |
| Flora Growth Corp | 17.30M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.651M |
| Revenue (Quarterly) | 40.44M |
| Total Expenses (Quarterly) | 39.15M |
| EPS Diluted (Quarterly) | -0.0044 |
| Gross Profit Margin (Quarterly) | 41.81% |
| Profit Margin (Quarterly) | -4.08% |
| Earnings Yield | -29.14% |
| Operating Earnings Yield | 15.08% |
| Normalized Earnings Yield | -15.00 |